The government is in advanced talks with US pharmaceutical giant Johnson & Johnson (J&J) to secure an additional 20-million doses of its Covid-19 vaccine, after plans to start inoculating health-care workers with AstraZeneca’s shot hit a major stumbling block at the weekend.

The Anglo-Swedish company’s offering was intended to be the cornerstone of the first phase of SA’s coronavirus vaccination drive, as it is relatively cheap and easy to store...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.